Tina Lenče
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 4
- Molecular Biology top 5%
- RNA modifications and cancer 9
- Cancer-related gene regulation 7
- RNA Research and Splicing 3
- RNA and protein synthesis mechanisms 2
-
- HVDC Systems and Fault Protection 2
-
- Helicobacter pylori-related gastroenterology studies 2
-
- Clostridium difficile and Clostridium perfringens research 2
- Co-authors
- Jean‐Yves RoignantMark HelmNastasja KreimMiguel A. Andrade‐NavarroMatthias SollerJunaid AkhtarMarc BayerKatharina Schmid
- Partner nations
- GermanySwitzerlandFrance
In The Last Decade
Tina Lenče
10 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Cancer Research 598
- Molecular Biology 1.3k
- Energy Engineering and Power Technology 23
- Electrical and Electronic Engineering 259
- Aging 5
Countries citing papers authored by Tina Lenče
This map shows the geographic impact of Tina Lenče's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Lenče with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Lenče more than expected).
Fields of papers citing papers by Tina Lenče
This network shows the impact of papers produced by Tina Lenče. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Lenče. The network helps show where Tina Lenče may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tina Lenče, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 15 | |
| 3 | 2021 | 113 | |
| 4 | 2020 | 36 | |
| 5 | 2020 | 34 | |
| 6 | 2018 | 97 | |
| 7 | 2018 | 75 | |
| 8 | Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)dbreakdown → | 2018 | 463 |
| 9 | 2017 | 56 | |
| 10 | 2017 | 67 | |
| 11 | m6A modulates neuronal functions and sex determination in Drosophilabreakdown → | 2016 | 425 |
About Tina Lenče
Tina Lenče is a scholar working on Cancer Research, Molecular Biology and Infectious Diseases, having authored 11 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related gene regulation (7 papers), Cancer-related molecular mechanisms research (4 papers), RNA Research and Splicing (3 papers), RNA and protein synthesis mechanisms (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and HVDC Systems and Fault Protection (2 papers). The work is most often cited by research in Cancer Research (598 citations), Molecular Biology (1.3k citations) and Energy Engineering and Power Technology (23 citations). Tina Lenče has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include Jean‐Yves Roignant, Mark Helm, Nastasja Kreim, Miguel A. Andrade‐Navarro, Matthias Soller, Junaid Akhtar, Marc Bayer, Katharina Schmid, Cheuk Hei Ho and Burkhard Poeck. Their work appears in journals such as Nature, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.